Exploring Hyaluronic Acid Upgrades for Eye Health Product Solutions

ヒアルロン酸 constitutes a vital component of the extracellular matrix and is widely distributed throughout tissues such as the skin, ocular vitreous humour, and synovial fluid.

Hyaluronic acid possesses excellent water solubility, high moisturising capacity, and favourable biocompatibility. Its rheological properties are highly compatible with ocular surface tissues, enabling it to form a durable, breathable protective film on the eye surface. Consequently, it serves as a key functional ingredient in ophthalmic health products such as eye drops and eye gels, effectively enhancing lubrication and comfort.

Within the field of ocular health products, hyaluronic acid powder has become a core functional ingredient in mid-to-high-end eye drops, ophthalmic gels, and post-operative care formulations due to its excellent biocompatibility with ocular surface tissues. It significantly enhances a formulation's moisturising properties, lubrication, and user comfort.

Green Spring Technology specialises in supplying high-purity, multi-molecular-weight hyaluronic acid powder. Our products exhibit outstanding rheological properties and batch consistency, making them suitable for developing and upgrading diverse eye care formulations. We assist clients in resolving technical challenges such as viscosity control, compatibility, and sustained moisturisation within product formulations, providing reliable raw material support for creating safer, gentler, and more comfortable eye health products.

1 Applications of Hyaluronic Acid Powder

As a natural biomaterial, hyaluronic acid powder demonstrates broad application potential across multiple fields due to its outstanding biocompatibility, exceptional water-retaining capacity, and unique rheological properties. Its safe, gentle nature and ease of formulation make it particularly suitable for eye health-related products.

Within the eye health sector, hyaluronic acid powder serves as an ideal moisturising and soothing ingredient in products such as eye drops, eye sprays, and eye patches. It helps alleviate dryness, provides gentle hydration, and enhances the comfort and sensory experience of formulations.

Green Spring Technology specialises in supplying high-purity, premium-quality hyaluronic acid powder, strictly adhering to international quality standards. We are committed to providing safe, reliable raw material support and solutions for clients developing next-generation eye health and personal care products.

1.1 Applications and Market Prospects of Hyaluronic Acid in Ophthalmology

Leveraging its exceptional viscoelasticity and molecular barrier properties, hyaluronic acid has become a vital viscoelastic protective agent and filler material in numerous ophthalmic procedures. It is also extensively incorporated into eye care solution formulations, significantly enhancing product adhesion and user comfort.

Currently, numerous ophthalmic products containing hyaluronic acid have secured regulatory approval in China, predominantly utilised as viscoelastic agents. This reflects the material's mainstream application direction in the current market, with substantial future development potential remaining.

1.2 Sodium Hyaluronate: An Exceptional Functional Ingredient for Premium Eye Lubricants

As a superior moisturising agent, sodium hyaluronate is extensively incorporated into diverse eye lubricants due to its unique viscoelasticity and exceptional water-retaining capacity. Its molecules contain numerous hydrophilic groups that effectively adsorb and lock in moisture, forming a gentle, breathable protective film on the ocular surface. This significantly enhances the lubricating sensation and comfort of the product.

Within formulations, sodium hyaluronate enhances rheological properties, prolonging residence time on the ocular surface to deliver sustained moisturising effects and improve user experience. Presently, this ingredient has become a favoured key functional component in mid-to-high-end eye care products.

1.3 Sodium Hyaluronate: A Critical Raw Material for Optimising Ophthalmic Formulations

As a high-performance pharmaceutical excipient, sodium hyaluronate plays a vital role in ophthalmic formulations. Its solution exhibits rheological properties similar to natural tears and offers excellent biocompatibility, making it an ideal drug carrier widely used in eye drops, ophthalmic gels, and other formulations.

In formulation applications, sodium hyaluronate effectively regulates product viscosity, improves retention time, and enhances application comfort.Compared to conventional thickeners, its unique rheological properties deliver a gentler, longer-lasting ocular sensation. Furthermore, sodium hyaluronate exhibits excellent compatibility with multiple active ingredients, optimising product performance through local administration and providing crucial technical support for ophthalmic formulation development.

1.4 Application Prospects of Hyaluronic Acid-Based Nanocarriers in Ocular Biomaterials

Nanoparticles composed of hyaluronic acid and biomaterials such as chitosan can serve as functional carriers in corneal and conjunctival bio-delivery applications. Research indicates that hyaluronic acid-chitosan nanoparticles promote alkaline phosphatase secretion, while hyaluronic acid-collagen composite nanoparticles exhibit excellent epithelial cell permeability and biocompatibility, demonstrating superior carrier performance across multiple experimental models.

This class of nanoparticle carrier systems offers novel approaches for innovation in ocular biomaterial technology. Differing from traditional modified hyaluronic acid delivery pathways, they demonstrate considerable application potential and developmental prospects.

2. Outlook

As a primary component of the extracellular matrix, hyaluronic acid is widely utilised across multiple fields—including ocular health, surgical care, skincare, and biomaterials—due to its outstanding biocompatibility, high hydrophilicity, excellent lubricating properties, and low antigenicity. It also demonstrates broad application potential in cutting-edge research such as tissue engineering.

Within eye health products, hyaluronic acid's unique rheological properties and moisturising lubrication characteristics establish it as a key functional ingredient in premium eye drops, ophthalmic gels, and post-operative care formulations. It significantly enhances product comfort and ocular affinity.

Green Spring Technology's hyaluronic acid powder boasts high purity, stable rheological properties, and excellent biocompatibility. Available in various molecular weight specifications, they meet the development needs of diverse eye care products, enabling clients to create safer, more comfortable, and more effective product experiences.

Please contact us at helen@greenspringbio.com or WhatsApp: +86 13649243917 to obtain further technical documentation and bespoke solutions for hyaluronic acid raw materials!

参照

[1] スターンrマイバッハh i .皮膚におけるヒアルロン酸:加齢とその薬理的変調の側面[j]。^パウサニアス、2008年(平成20年)12月26日、106- 122頁。

[2] マイヤーKはパーマーJ w知ってglycoproteinsたガラスユーモアとへその緒の多糖類[j]。^ a b c d e f g h『人事興信録』第4版、1029 - 1033頁。

[3] sudha p n, rose m h .ヒアルロン酸の有益な効果[j]。^『仙台市史』通史編、仙台市、2014年、137-176頁。

【4】劉徽、劉阿娟。ヒアルロン酸、化粧品の神聖な製品[j]。2012年(平成24年)-化学科を設置。

[5]王Juanqin。ヒアルロン酸の修飾と機能化[d]。『漢学』南山大学、2013年。

[6] xu jing, ai ling, bai huiyu, et al。ヒアルロン酸修飾に関する研究の進展[j]。polymer bulletin, 2011, 2:78 -84。

[7] pang suqiu, zhou jinsheng, chen qiuxia, et al。ヒアルロン酸ナトリウムの臨床応用[j]。2003年(平成15年)4月15日:ダイヤ改正。

【8】凌peixue、関華史。ヒアルロン酸とその誘導体の抗接着における研究と応用[j]。中国医薬ジャーナル、2005年、40(20):1527-1530。

[9] Kaderli s, boulocher c, pillet e, et al。骨関節症治療のための新しい生体適合性ヒアルロン酸-キトサンハイブリッドハイドロゲル[j]。2015年Int J Pharm、483問(以上1分け1敗):158-168。

[10] gencer zk, zkiri s m, okur a, et al。顎関節障害の訴えに対するヒアルロン酸、テノキシカム、ベタメタゾンの関節内注射の影響に関する比較研究[j]。^ a b c d e f g h i j craniomaxillofac surg, 2014, 42(7): 1117-1121。

[11] voigt j, driver v r .火傷、上皮性外科的創傷、および慢性創傷に対するヒアルロン酸誘導体とその治癒効果:ランダム化比較試験のシステマティックレビューおよびメタ分析[j]。^『仙台市史』通史編、仙台市、2012年(平成24年)、317-331頁。

[12] hanci d, altun h .扁桃摘出後の痛み緩和および創傷治癒におけるヒアルロン酸の有効性-前向き、二重盲検、対照臨床研究[j]。int j pediatric otorhinolaryngol, 2015,79(9): 1388-1392。